Extracorporeal Shock Wave Lithotripsy Best at 90 Pulses/Min

This article originally appeared here.
Share this content:
Extracorporeal Shock Wave Lithotripsy Best at 90 Pulses/Min
Extracorporeal Shock Wave Lithotripsy Best at 90 Pulses/Min

(HealthDay News) -- For ureteral stones, extracorporeal shock wave lithotripsy delivered at a shock wave delivery rate of 90 pulses per minute is associated with excellent outcomes, according to a study published in the August issue of The Journal of Urology.

Daniel P. Nguyen, M.D., from the University of Bern in Switzerland, and colleagues compared the outcomes of two delivery rates in a prospective randomized trial involving 254 consecutive patients with solitary ureteral stones. Participants were randomized to receive extracorporeal shock wave lithotripsy at a shock wave delivery rate of 60 and 90 pulses per minute (130 and 124 participants, respectively).

The researchers found that at three months, the stone-free rate was significantly higher in patients who underwent extracorporeal shock wave lithotripsy at a shock wave delivery rate of 90 pulses versus 60 pulses per minute (91 versus 80 percent; P = 0.01). The observed difference was due to patients with proximal (100 versus 83 percent; P = 0.005) and mid ureteral (96 versus 73 percent, respectively; P = 0.03) stones, but not those with distal ureteral stones (81 versus 80 percent; P = 0.9). Independent predictors of success included shock wave delivery rate of 90 pulses per minute, proximal stone location, stone density, stone size, and an absent indwelling Double-J stent, on multivariable analysis.

"Optimizing the extracorporeal shock wave lithotripsy delivery rate can achieve excellent results for ureteral stones," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

FDA Approves 'Artificial Pancreas' for Type 1 Diabetes

FDA Approves 'Artificial Pancreas' for Type 1 Diabetes

MiniMed 670G hybrid closed loop system automatically monitors glucose, delivers insulin

More Evidence HPV Vaccine Protects Against Cervical Cancer

More Evidence HPV Vaccine Protects Against Cervical Cancer

Protection appears to occur even when only one or two of the recommended doses are given

Prescribed NSAIDs Tied to Higher Heart Failure Risk

Prescribed NSAIDs Tied to Higher Heart Failure Risk

Study of millions of health records suggests an association

is free, fast, and customized just for you!

Already a member?

Sign In Now »